Neuroendocrine insights from the laboratory to the clinic

被引:15
作者
Ahlman, H
Nilsson, O
Wangberg, B
Dahlstrom, A
机构
[1] GOTHENBURG UNIV,SAHLGRENS HOSP,DEPT PATHOL,S-41345 GOTHENBURG,SWEDEN
[2] GOTHENBURG UNIV,DEPT ANAT & CELL BIOL,GOTHENBURG,SWEDEN
关键词
D O I
10.1016/S0002-9610(96)00078-5
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: The interaction between adrenergic nerves and enterochromaffin (EC) cells was studied in health and disease using animal models and patients with the midgut carcinoid syndrome. METHODS: The methods included morphological techniques (fluorescence microscopy/cytofluorimetry, electronmicroscopy), experimental models (in vivo/in vitro nerve stimulation, pharmacological analyses, axonal transport, tumor transplantation, tumor cell cultures) and clinical tests (pentagastrin provocation, octreotide scintigraphy). RESULTS: From vagal nerve stimulation studies it was clear that activation of adrenergic fibers could release serotonin (5-HT) from EC cells, which led to the mapping of a vagal adrenergic pathway. Ultrastructurally a direct innervation of EC cells was demonstrated. It was confirmed in vitro that adrenoceptors controlled the release of 5-HT; it was maintained in neoplasia as studied in the tumor models. The tumor cells shared several functional and morphological characteristics with adrenergic neurons and exerted trophic actions on neurons grown in co-culture. CONCLUSIONS: Pentagastrin provocation of 5-HT release in carcinoid patients may be mediated via release of catecholamines from the adrenals in turn activating adrenoceptors on tumor cells. Pretreatment with a somatostatin analog can reduce these reactions and thus minimize the risk for carcinoid crisis during surgery.
引用
收藏
页码:61 / 67
页数:7
相关论文
共 40 条
[1]  
AHLMAN H, 1988, ANESTH ANALG, V67, P1142
[2]  
AHLMAN H, 1990, BIOGENIC AMINES, V7, P399
[3]   ON THE PRESENCE OF SEROTONIN IN THE GUT LUMEN AND POSSIBLE RELEASE MECHANISMS [J].
AHLMAN, H ;
BHARGAVA, HN ;
DAHLSTROM, A ;
LARSSON, I ;
NEWSON, B ;
PETTERSSON, G .
ACTA PHYSIOLOGICA SCANDINAVICA, 1981, 112 (03) :263-269
[4]  
AHLMAN H, 1985, ANN SURG, V201, P81
[5]   CARCINOID-TUMOR CELLS IN LONG-TERM CULTURE - RELEASE OF SEROTONIN BUT NOT OF TACHYKININS ON STIMULATION WITH ADRENOCEPTOR AGONISTS [J].
AHLMAN, H ;
AHLUND, L ;
NILSSON, O ;
SKOLNIK, G ;
THEODORSSON, E ;
DAHLSTROM, A .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (04) :506-510
[6]   PRESENCE OF NERVE GROWTH FACTOR-LIKE IMMUNOREACTIVITY IN CARCINOID-TUMOR CELLS AND INDUCTION OF A NEURONAL PHENOTYPE IN LONG-TERM CULTURE [J].
AHLMAN, H ;
WIGANDER, A ;
MOLNE, J ;
NILSSON, O ;
KARLSSON, JE ;
THEODORSSON, E ;
DAHLSTROM, A .
INTERNATIONAL JOURNAL OF CANCER, 1989, 43 (05) :949-955
[7]   RELEASE OF IMMUNOREACTIVE SEROTONIN INTO THE LUMEN OF THE FELINE GUT IN RESPONSE TO VAGAL NERVE-STIMULATION [J].
AHLMAN, H ;
DEMAGISTRIS, L ;
ZINNER, M ;
JAFFE, BM .
SCIENCE, 1981, 213 (4513) :1254-1255
[8]   CLINICAL EFFICACY OF OCTREOTIDE SCINTIGRAPHY IN PATIENTS WITH MIDGUT CARCINOID-TUMORS AND EVALUATION OF INTRAOPERATIVE SCINTILLATION DETECTION [J].
AHLMAN, H ;
WANGBERG, B ;
TISELL, LE ;
NILSSON, O ;
FJALLING, M ;
FORSSELLARONSSON, E .
BRITISH JOURNAL OF SURGERY, 1994, 81 (08) :1144-1149
[9]   MANAGEMENT OF DISSEMINATED MIDGUT CARCINOID-TUMORS [J].
AHLMAN, H ;
WANGBERG, B ;
JANSSON, S ;
STENQVIST, O ;
GETERUD, K ;
TYLEN, U ;
CAIDAHL, K ;
SCHERSTEN, T ;
TISELL, LE .
DIGESTION, 1991, 49 (02) :78-96
[10]   GROWTH-REGULATION IN CARCINOID-TUMORS [J].
AHLMAN, H ;
WANGBERG, B ;
NILSSON, O .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1993, 22 (04) :889-915